Kirstine Sandal Nørregaard
Postdoc
Behrendt Group
Ole Maaløes Vej 5, 2200 København N.
Member of:
ORCID: 0000-0002-1299-0991
1 - 1 out of 1Page size: 10
- 2016
- Published
Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180
Engelholm, Lars Henning, Carlsen Melander, E. M., Hald, A., Persson, M., Madsen, D. H., Jürgensen, Henrik Jessen, Johansson, K., Nielsen, C., Nørregaard, Kirstine Sandal, Ingvarsen, S. Z., Kjær, Andreas, Trovik, C. S., Lærum, O. D., Bugge, T. H., Eide, J. & Behrendt, Niels, Jan 2016, In: Journal of Pathology. 238, 1, p. 120-33 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 152298545
Most downloads
-
263
downloads
The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
40
downloads
Tumor cell MT1-MMP is dispensable for osteosarcoma tumor growth, bone degradation and lung metastasis
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
18
downloads
Osteosarcoma and metastasis associated bone degradation—a tale of osteoclast and malignant cell cooperativity
Research output: Contribution to journal › Journal article › Research › peer-review
Published